NASDAQ:ARDX
Ardelyx Stock News
$6.42
+0.110 (+1.74%)
At Close: Apr 26, 2024
Will Ardelyx Continue to Surge Higher?
02:44pm, Tuesday, 12'th May 2020
As of late, it has definitely been a great time to be an investor Ardelyx
Ardelyx (ARDX) Upgraded to Strong Buy: Here's Why
04:00pm, Monday, 11'th May 2020
Ardelyx (ARDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Analysts Are Upgrading Ardelyx, Inc. (NASDAQ:ARDX) After Its Latest Results
12:16pm, Sunday, 10'th May 2020
As you might know, Ardelyx, Inc. (NASDAQ:ARDX) just kicked off its latest first-quarter results with some very strong...
Ardelyx Q1 EPS $(0.250) Up From $(0.420) YoY, Sales $1.213M
08:23pm, Thursday, 07'th May 2020Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
08:02pm, Thursday, 07'th May 2020
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,
Here's Why Momentum Investors Will Love Ardelyx (ARDX)
04:00pm, Tuesday, 28'th Apr 2020
Does Ardelyx (ARDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ardelyx Inc (NASDAQ:ARDX) Stake Raised by Bank of New York Mellon Corp
09:34am, Friday, 24'th Apr 2020
Bank of New York Mellon Corp boosted its holdings in Ardelyx Inc (NASDAQ:ARDX) by 5.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange C
What Did Ardelyx, Inc.'s (NASDAQ:ARDX) CEO Take Home Last Year?
10:14am, Thursday, 23'rd Apr 2020
Mike Raab has been the CEO of Ardelyx, Inc. (NASDAQ:ARDX) since 2009. This report will, first, examine the CEO...
Michael Raab Sells 9,428 Shares of Ardelyx Inc (NASDAQ:ARDX) Stock
09:34am, Sunday, 19'th Apr 2020
Ardelyx Inc (NASDAQ:ARDX) CEO Michael Raab sold 9,428 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $7.02, for a total tr
Knight Therapeutics Announces Approval of IBSRELA™ in Canada
11:30am, Friday, 17'th Apr 2020
MONTREAL, April 17, 2020 -- Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced that Health Canada has approved.
Ardelyx Inc (NASDAQ:ARDX) Shares Bought by Cubist Systematic Strategies LLC
09:06am, Thursday, 16'th Apr 2020
Cubist Systematic Strategies LLC raised its stake in Ardelyx Inc (NASDAQ:ARDX) by 34.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SE
37,649 Shares in Ardelyx Inc (NASDAQ:ARDX) Purchased by AQR Capital Management LLC
08:40am, Monday, 13'th Apr 2020
AQR Capital Management LLC acquired a new position in shares of Ardelyx Inc (NASDAQ:ARDX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & E
Credit Suisse AG Raises Position in Ardelyx Inc (NASDAQ:ARDX)
09:28am, Saturday, 11'th Apr 2020
Credit Suisse AG increased its position in Ardelyx Inc (NASDAQ:ARDX) by 87.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26
Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
01:00pm, Monday, 16'th Mar 2020
Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announc
Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
12:15pm, Monday, 09'th Mar 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
